Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Mass.
Division of Vascular and Endovascular Surgery, Boston University, School of Medicine, Boston, Mass.
J Vasc Surg. 2019 May;69(5):1421-1428. doi: 10.1016/j.jvs.2018.07.066. Epub 2018 Nov 23.
Renal dysfunction is a well-described complication of open juxtarenal abdominal aortic aneurysm repair, but the associated risk factors and corresponding impact on survival are not well described.
We identified all patients not on hemodialysis undergoing open repair of nonruptured juxtarenal aneurysms in the Vascular Quality Initiative from 2003 to 2017. We used mixed-effects logistic regression to determine factors associated with in-hospital postoperative renal dysfunction, including acute kidney injury (AKI, defined as serum creatinine concentration increase >0.5 mg/dL) and new renal replacement therapy (RRT), as well as the association between postoperative renal function and perioperative mortality. Cox regression was used to determine the association between postoperative renal complications and long-term survival.
We identified 2635 open juxtarenal repairs, of which 621 (24%) were complicated by AKI. The majority of these (20% of the overall cohort) were AKI alone, but 2.2% required temporary RRT and an additional 1.7% were permanently dialysis dependent. Factors independently associated with postoperative renal dysfunction included renal-visceral ischemia time (per minute: odds ratio [OR], 1.01 [1.01-1.02]; P < .001), clamp site (above both renal arteries: OR, 1.4 [1.1-1.8; P = .02]; supraceliac: OR, 1.7 [1.1-2.5; P = .01]), statin use (OR, 1.5 [1.1-2.0]; P = .01), male sex (OR, 1.7 [1.2-2.2]; P = .002), and preoperative renal function (glomerular filtration rate [GFR] of 45-60 mL/min/1.73 m: OR, 1.8 [1.3-2.5; P < .001]; GFR of 30-45 mL/min/1.73 m: OR, 1.9 [1.2-2.8; P = .003]; GFR of <30 mL/min/1.73 m: OR, 6.2 [3.1-12.2; P < .001]). When renal-visceral ischemia time was categorized, there was no difference in risk of postoperative renal dysfunction until >25 minutes, but risk increased stepwise thereafter (25-39 minutes: OR, 1.6 [1.2-2.1; P = .004]; 40+ minutes: OR, 2.6 [1.9-3.5; P < .001]). Neither mannitol nor the use of cold renal perfusion was associated with renal complications or mortality in the overall cohort, but cold renal perfusion was associated with lower risk of AKI when clamp times exceeded 25 minutes (OR, 0.4 [0.2-0.97]; P = .041). Postoperative renal dysfunction was associated with higher adjusted perioperative mortality (AKI: OR, 2.6 [1.4-5.0; P < .01]; RRT: OR, 10.5 [4.0-27.6; P < .001]) and significantly higher risk of long-term mortality (AKI: hazard ratio, 1.5 [1.0-2.1; P = .049]; RRT: hazard ratio, 5.8 [3.2-10.3; P < .001]).
Postoperative renal dysfunction, even a mild elevation in creatinine concentration, is associated with higher perioperative and long-term mortality. Although the routine use of mannitol and cold renal perfusion was not associated with postoperative renal dysfunction after open juxtarenal repair, cold renal perfusion was associated with lower risk of AKI if clamp times exceeded 25 minutes.
肾功能障碍是开放性肾周腹主动脉瘤修复后描述明确的并发症,但相关的风险因素及其对生存率的影响尚不清楚。
我们在 2003 年至 2017 年期间从血管质量倡议中确定了所有未接受血液透析且正在接受非破裂肾周动脉瘤开放性修复的患者。我们使用混合效应逻辑回归来确定与住院术后肾功能障碍相关的因素,包括急性肾损伤(AKI,定义为血清肌酐浓度升高>0.5mg/dL)和新的肾脏替代治疗(RRT),以及术后肾功能与围手术期死亡率之间的关系。Cox 回归用于确定术后肾脏并发症与长期生存之间的关系。
我们确定了 2635 例开放性肾周修复术,其中 621 例(24%)并发 AKI。这些患者中的大多数(总体队列的 20%)只有 AKI,但有 2.2%需要临时 RRT,还有 1.7%需要永久性透析。与术后肾功能障碍相关的独立因素包括肾内脏缺血时间(每分钟:优势比[OR],1.01[1.01-1.02];P<0.001)、夹闭部位(肾动脉以上:OR,1.4[1.1-1.8;P=0.02];腹主动脉以上:OR,1.7[1.1-2.5;P=0.01])、他汀类药物的使用(OR,1.5[1.1-2.0;P=0.01])、男性(OR,1.7[1.2-2.2];P=0.002)和术前肾功能(肾小球滤过率[GFR]为 45-60ml/min/1.73m:OR,1.8[1.3-2.5;P<0.001];GFR 为 30-45ml/min/1.73m:OR,1.9[1.2-2.8;P=0.003];GFR<30ml/min/1.73m:OR,6.2[3.1-12.2;P<0.001])。当肾内脏缺血时间分类时,直到>25 分钟后才会出现术后肾功能障碍的风险增加,但此后风险呈阶梯式增加(25-39 分钟:OR,1.6[1.2-2.1;P=0.004];40+分钟:OR,2.6[1.9-3.5;P<0.001])。甘露醇和使用冷肾灌注与整体队列的肾脏并发症或死亡率均无关,但当夹闭时间超过 25 分钟时,冷肾灌注与 AKI 风险降低相关(OR,0.4[0.2-0.97];P=0.041)。术后肾功能障碍与调整后的围手术期死亡率较高相关(AKI:OR,2.6[1.4-5.0;P<0.01];RRT:OR,10.5[4.0-27.6;P<0.001]),并且与长期死亡率显著增加相关(AKI:危险比,1.5[1.0-2.1;P=0.049];RRT:危险比,5.8[3.2-10.3;P<0.001])。
即使是肌酐浓度的轻度升高,术后肾功能障碍也与围手术期和长期死亡率较高相关。虽然在开放性肾周修复术后,常规使用甘露醇和冷肾灌注与术后肾功能障碍无关,但如果夹闭时间超过 25 分钟,冷肾灌注与 AKI 的风险降低相关。